Form D · Venture Capital Fund

Abingworth Clinical Co-Development Fund LP

London, X0 · CIK 0001658235

Offering snapshot reported Nov 23, 2015 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 23, 2015InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0
Form D file number
021-251729
Sales commissions to the placement agent will be equal to a percentage of the aggregate principal amount of securities sold.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Asante Capital Group LLP155178Asante Capital Group Advisors LLC

Source: Form D, filed Nov 23, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

ABINGWORTH CLINICAL CO-DEVELOPMENT FUND LP

Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.

Gross asset value
$51.5M
Beneficial owners
26
ADV minimum commitment
$0

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STATE STREET ADMINISTRATION SERVICES (UK) LIMITED LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →
Auditor ERNST & YOUNG LLP LONDON, United Kingdom Other funds reporting this name →
Custodian BARCLAYS BANK PLC (LONDON) LONDON, United Kingdom Related to adviser: No Other funds reporting this name →
Custodian JPMORGAN CHASE BANK, N.A. (NEW YORK) NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Custodian STATE STREET TRUSTEES LIMITED LONDON, United Kingdom Related to adviser: No Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ERNST & YOUNG LLP
PCAOB 1438

Fund asset history · 4 annual observations Gross asset value by annual ADV filing$0$64.6M$129MFY 2022: $129,100,000.00FY 2022FY 2023: $82,404,131.00FY 2023FY 2024: $50,996,756.00FY 2024FY 2025: $51,542,176.00FY 2025

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2022$129,100,00013Mar 30, 2023
2023$82,404,13113Mar 27, 2024
2024$50,996,75613Mar 31, 2025
2025$51,542,17626Mar 31, 2026
Filing source

Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-4515384707

Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

Matched by reported Form D file number

ABINGWORTH CLINICAL CO-DEVELOPMENT FUND LP

Investment adviser: ABINGWORTH MANAGEMENT INC.

Gross asset value
$125M
Beneficial owners
13
ADV minimum commitment
$200K

Reported in Form ADV on Oct 31, 2022. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STATE STREET ADMINISTRATION SERVICES (UK) LIMITED LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →
Auditor DELOITTE LLP LONDON, United Kingdom Other funds reporting this name →
Custodian SANNE FIDUCIARY SERVICES (UK) LIMITED LONDON, United Kingdom Related to adviser: No Other funds reporting this name →
Custodian STATE STREET TRUSTEES LIMITED LONDON, United Kingdom Related to adviser: No Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

DELOITTE LLP
PCAOB 1147

Fund asset history · 2 annual observations Gross asset value by annual ADV filing$0$62.7M$125MFY 2021: $116,590,000.00FY 2021FY 2022: $125,423,000.00FY 2022

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2021$116,590,00013Oct 1, 2021
2022$125,423,00013Sep 2, 2022
Filing source

Form ADV 1674054 · Oct 31, 2022 · Schedule D 7.B.(1), fund 805-4515384707

Reported by ABINGWORTH MANAGEMENT INC. (CRD 157466).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
General Partner Abingworth Clinical Co Development Fund Gp Lp Promoter
Manager Abingworth Llp Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Abingworth Llp 38 Jermyn Street
London, X0, SW1Y 6DN
Phone: 4402075341500